Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New Non-Hormonal device aims to ease endometriosis pain at home

NCT ID NCT05643131

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study tests a new intravaginal device that uses gentle heat and stretching to help manage chronic pelvic pain in people with endometriosis. Twenty participants will use the device at home three times a week for 12 weeks. The goal is to see if it reduces pain and improves quality of life without hormones.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hyivy Intravaginal Device (heat and dilation therapy)
What this could lead to
If it works, this could offer a non-hormonal, at-home option to manage endometriosis-related pelvic pain.
What could go wrong
This is a very small, early pilot study with no control group, so results may not be conclusive. The device may not reduce pain for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1.Age ≥ 18 at the time of enrollment * 2.Generally in good health (other than due to endometriosis), at physician's discretion * 3.Diagnosed with endometriosis (clinical, radiologic, or surgical) * 4.Diagnosed with chronic pelvic pain (self-reported pain in pelvic area lasting \>3 months) * 5.VAS for overall pelvic pain ≥ 4 at screening and baseline * 6.Medically managing endometriosis using continuous hormonal medications (i.e., oral contraceptive pills, progesterone only pills, Mirena, GnRH agonists/antagonists) for at least 3 months prior to enrollment * 7.Agrees not to commence any new treatments (medical or physical therapies) for the 12-week intervention period, including hormonal therapies for any medical condition, and complimentary and/or alternative management of surgery for endometriosis and associated chronic pain * 8.Agrees not to undergo pelvic physiotherapy with a trained professional during the study * 9.Agrees to avoid taking non-steroidal anti-inflammatory drugs (e.g., ibuprofen) for 72 hours before Visits 1, 2, and 3 * 10.Must have the ability to charge the investigational device * 11.Must be willing and able to insert intravaginal device * 12.Able to understand, comply and consent to protocol requirements and instructions * 13.Able to attend scheduled study visits and complete required investigations Exclusion Criteria: * 1.Chronic pelvic pain thought to be due to a condition other than endometriosis * 2.Diagnosis of premature ovarian insufficiency * 3.Any other medical condition or clinical finding giving reasonable suspicion of a disease or condition that contraindicates the use of the investigational product or that may affect the interpretation of the results or leave the patient at high risk from treatment complications, at the discretion of the investigator(s) * 4.Any surgery in the past 3 months or anticipates having surgery during the study * 5.Allergy to Hyivy device's materials * 6.Active vaginal infection (e.g. vulvovaginal candidiasis, trichomonas vaginitis, bacterial vaginosis, STIs) or infection in the pelvic area * 7.Current use of antibiotics and a history of vulvovaginal candidiasis * 8.Pregnant or lactating * 9.Currently under the care of a pelvic floor physiotherapist * 10.Have open wounds, cuts, or open sores present in vaginal or pelvic area * 11.Severe atrophic vaginitis or very dry, itchy, or sore vagina/vaginal area, at the discretion of the primary investigator(s) * 12.Hypoesthesia or loss in sensation of the pelvic floor * 13.Total and/or partial prolapse of the uterus and/or vagina * 14.Symptoms of severe urinary retention, severe extra-urethral incontinence or overflow incontinence * 15.Unable to position the device according to directions for use * 16.Use of any medical devices that may interfere with the investigational device's function, such as pacemakers, ventilators, and ear implants

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometriosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometriosis Pelvic Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • McMaster University Medical Centre

    Hamilton, Ontario, L8N 3Z5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.